RaymondHMakMD

Thoracic Cancer

Associate Professor of Radiation Oncology, Brigham and Women's Hospital / Dana-Farber Cancer Institute / Harvard Medical School

Dr. Mak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
75 Francis St
Asb1l2 Radiation Oncology Brigham Womens Hospital
Boston, MA 02115
Phone+1 617-732-5500

I am an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.

My clinical focus includes the treatment of thoracic malignancies, stereotactic body radiation therapy, and novel image-guided radiation therapy techniques. I led the implementation of the MR-guided radiation therapy program at BWH/DFCI in 2019.

My research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients and applying artificial intelligence techniques to automate radiation therapy planning and improve cancer care.

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2007 - 2011
Brigham and Women's HospitalResidency, Internal Medicine, 2006 - 2007
Harvard Medical SchoolClass of 2006

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC) Start of enrollment: 2012 Nov 01
Terminated
Not Applicable
Jump: MR Simulation For Radiation Therapy Master Protocol Start of enrollment: 2020 Oct 14
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
CONFIRM: Magnetic Resonance Guided Radiation Therapy Start of enrollment: 2021 May 01
Suspended
Not Applicable
Roles: Contact, Principal Investigator

PubMed

7446 citations
MicroRNA expression profiles classify human cancers
Jun Lu, Gad Getz, Eric A. Miska, Ezequiel Alvarez-Saavedra, Justin Lamb
Nature. 2005-06-09
693 citations
Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis
Noa Novershtern, Aravind Subramanian, Lee N. Lawton, Raymond H. Mak, W. Nicholas Haining
Cell. 2011-01-21
13 citations
Elevated Coronary Artery Calcium Quantified by a Validated Deep Learning Model From Lung Cancer Radiotherapy Planning Scans Predicts Mortality.
Katelyn M Atkins, Jakob Weiss, Roman Zeleznik, Danielle S Bitterman, Tafadzwa L Chaunzwa
JCO Clinical Cancer Informatics. 2022-01-01

Journal Articles

Association of Left Anterior Descending Coronary Artery Radiation Dose with Major Adverse Cardiac Events and Mortality in Patients with Non–Small Cell Lung Cancer
Katelyn M Atkins, David E Kozono, Elizabeth H Baldini, Raymond H Mak, JAMA Oncology

Making Radiation Therapy Safer for the HeartSeptember 13th, 2024
Lung Cancer Radiotherapy Linked to Cardiac Complications Due to RadiationAugust 24th, 2024
AI Helps Predict Cardiac Arrhythmias in Lung Cancer Patients, Research RevealsAugust 23rd, 2024
Join now to see all